Poly(γ-glutamic acid), coagulation? Anticoagulation?

J Biomater Sci Polym Ed. 2016 Nov;27(16):1599-610. doi: 10.1080/09205063.2016.1221700. Epub 2016 Aug 22.

Abstract

Poly(γ-glutamic acid) (γ-PGA) powder was usually used as hemostatic agent because of its excellent physical properties of water-absorption and water-locking. However, if γ-PGA absorbs enough water, how about its blood compatibility? Here, the other side of the coin was investigated. The anticoagulant properties of γ-PGA were characterized by in vitro coagulation tests, hemolytic assay, platelet adhesion, and platelet activation. Moreover, cytotoxicity experiments of γ-PGA were also carried out by MTT assay. Results indicated that the sufficient water-absorbed γ-PGA has good anticoagulant property and non-cytotoxicity. It means γ-PGA has good anticoagulant property, non-cytotoxicity. If γ-PGA has absorbed enough water, it can be used as an anticoagulation biomaterial. With double effects (coagulation and anticoagulation), the γ-PGA with desirable bioproperties can be readily tailored to cater to various biomedical applications.

Keywords: Poly(γ-glutamic acid); anticoagulation; coagulation; cytotoxicity; water-absorption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials / pharmacology*
  • Blood Coagulation / drug effects*
  • Hemolysis / drug effects
  • Platelet Activation / drug effects
  • Platelet Adhesiveness / drug effects
  • Polyglutamic Acid / analogs & derivatives*
  • Polyglutamic Acid / pharmacology
  • Rabbits

Substances

  • Biocompatible Materials
  • poly(gamma-glutamic acid)
  • Polyglutamic Acid